Incidence of hospitalization due to community-acquired rotavirus infection: A 12-year study (1996-2008)

Epidemiology and Infection

Volumn 138, Issue 9, 2010, Pages 1235-1241

  Cilla, G ^a   Gomariz, M ^a   Montes, M ^a   Mendiburu, M I ^a   Perez Yarza E G ^a,b   Perez Trallero E ^a,b  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Community epidemics; incidence; rotavirus

Indexed keywords

VIRUS ANTIGEN;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; COMMUNITY CARE; CONTROLLED STUDY; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; GENOTYPE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORAL REHYDRATION THERAPY; PRESCHOOL CHILD; ROTAVIRUS; ROTAVIRUS INFECTION; SEASONAL VARIATION; VIRUS DETECTION; ACUTE DISEASE; CHI SQUARE DISTRIBUTION; COMMUNICABLE DISEASE; GASTROENTERITIS; LONGITUDINAL STUDY; SPAIN; STATISTICS; VIROLOGY;

ACUTE DISEASE; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALE; ROTAVIRUS INFECTIONS; SPAIN;

EID: 77956625241     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881000004X     Document Type: Article

References (23)

1. Parashar UD, et al. Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 2003;9:565-572.
2. Williams CJ, Lobanov A, Pebody RG. Estimated mortality and hospital admission due to rotavirus infection in the WHO European region. Epidemiology and Infection 2009;137:607-616.
3. Ruiz-Palacios GM, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 2006;354:11-22.
4. Vesikari T, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 2006;354:23-33. (Pubitemid 43048948)
5. Patel M, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. Journal of the American Medical Association 2009;301:2243-2251.
6. Cilla G, et al. Hospitalizations for rotavirus gastroenteritis in Gipuzkoa (Basque country), Spain. Emerging Infectious Diseases 1999;5:834-835.
7. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. Journal of Clinical Virology 2004;31:259-265.
8. Centers for Disease Control and Prevention (CDC). Rotavirus surveillance x worldwide, 2001-2008. Morbidity and Mortality Weekly Report 2008;57:1255-1257.
9. Atchison CJ, et al. Clinical laboratory practices for the detection of rotavirus in England and Wales: can surveillance based on routine laboratory testing data be used to evaluate the impact of vaccination? Eurosurveillance 2009;14: pii: 19217. (http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId= 19217). Accessed 2 September 2009.
10. Patel MM, et al. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatric Infectious Disease Journal 2007;26:914-919.
11. Chang HG, et al. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatric Infectious Disease Journal 2003;22:808-814.
12. Payne DC, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008;122:1235-1243.
13. Hsu VP, et al. Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics 2005;115:78-82.
14. Parashar UD, et al. Rotavirus and severe childhood diarrhea. Emerging Infectious Diseases 2006;12:304-306.
15. Forster J, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009;123: e393-400.
16. Pont SJ, et al. Trends in healthcare usage attributable to diarrhea, 1995-2004. Journal of Pediatrics 2008;153:777-782.
17. Martinot A, et al. Improvement in the management of acute diarrhoea in France? Archives de Pediatrie 2007;14(Suppl. 3): S181-185.
18. Bellemare S, et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Medicine 2004;2:11 (http://www.biomedcentral. com/1741-7015/2/11). Accessed 2 September 2009.
19. Velazquez FR, et al. Rotavirus infections in infants as protection against subsequent infections. New England Journal of Medicine 1996;335:1022-1028.
20. Cilla G, et al. Incidence, seasonality and serotypes of rotavirus in Gipuzkoa (Basque Country), Spain. A 14-year study. Epidemiology and Infection 2000;125:677-683.
21. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Reviews of Medical Virology 2005;15:29-56.
22. Sanchez-Fauquier A, et al. Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain. Emerging Infectious Diseases 2006;12:1536-1541.
23. Van Damme P, et al. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. Journal of Infectious Diseases 2007;195(Suppl. 1): S4-16.